Advanced search
Publication Cover
Journal of Chemotherapy Volume 35, 2023 - Issue 7
Submit an article Journal homepage
223
Views
0
CrossRef citations to date
0
Altmetric
Antimicrobial Original Research Papers

Looking for Stenotrophomonas maltophilia treatment: in vitro activity of ceftazidime/avibactam alone and in combination with aztreonam

Enrica Maddalena Ranieria Section of Microbiology and Virology, University of Bari, Bari, Italy
,
Sofia Denicolòa Section of Microbiology and Virology, University of Bari, Bari, Italy
,
Stefania Stolfaa Section of Microbiology and Virology, University of Bari, Bari, Italy
,
Lidia Dalfinob Anesthesia and Intensive Care Unit, Department of Emergency and Organ Transplantation, University of Bari, Bari, Italy
,
Davide Fiore Bavaroc Clinic of Infectious Diseases, University of Bari, Bari, Italy
,
Annalisa Saracinoc Clinic of Infectious Diseases, University of Bari, Bari, Italy
,
Luigi Rongaa Section of Microbiology and Virology, University of Bari, Bari, Italy
,
Raffaele Del Pretea Section of Microbiology and Virology, University of Bari, Bari, Italy
&
Adriana Moscaa Section of Microbiology and Virology, University of Bari, Bari, ItalyCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-7646-2370
ORCID Icon show all
Pages 610-613 | Received 27 Dec 2022, Accepted 02 May 2023, Published online: 24 Aug 2023

References

  • Brooke JS. Stenotrophomonas maltophilia: an emerging global opportunistic pathogen. Clin Microbiol Rev. 2012;25(1):2–41. doi: 10.1128/CMR.00019-11.
  • Wang N, Tang C, Wang L. Risk factors for acquired Stenotrophomonas maltophilia pneumonia in intensive care unit: a systematic review and meta-analysis. Front Med (Lausanne). 2021;8:808391. doi: 10.3389/fmed.2021.808391.
  • Ibn Saied W, Merceron S, Schwebel C, et al. Ventilator-associated pneumonia due to Stenotrophomonas maltophilia: risk factors and outcome. J Infect. 2020;80(3):279–285. doi: 10.1016/j.jinf.2019.10.021.
  • Son HJ, Kim T, Lee E, et al. Risk factors for isolation of multi-drug resistant organisms in coronavirus disease 2019 pneumonia: a multicenter study. Am J Infect Control. 2021;49(10):1256–1261. doi: 10.1016/j.ajic.2021.06.005.
  • Chong WH, Saha BK, Ananthakrishnan Ramani, Chopra A. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia. Infection. 2021;49(4):591–605 doi: 10.1007/s15010-021-01602-z.
  • Pek Z, Cabanilla MG, Ahmed S. Treatment refractory Stenotrophomonas maltophilia bacteraemia and pneumonia in a COVID-19-positive patient. BMJ Case Rep. 2021;14(6):e242670. doi: 10.1136/bcr-2021-242670.
  • Nicodemo AC, Paez JI. Antimicrobial therapy for Stenotrophomonas maltophilia infections. Eur J Clin Microbiol Infect Dis. 2007;26(4):229–237. doi: 10.1007/s10096-007-0279-3.
  • Calvopiña K, Hinchliffe P, Brem J, et al. Structural/mechanistic insights into the efficacy of nonclassical β-lactamase inhibitors against extensively drug resistant Stenotrophomonas maltophilia clinical isolates. Mol Microbiol. 2017;106(3):492–504. doi: 10.1111/mmi.13831.
  • Ko JH, Kang CI, Cornejo-Juárez P, et al. Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis. Clin Microbiol Infect. 2019;25(5):546–554. doi: 10.1016/j.cmi.2018.11.008.
  • Moriceau C, Eveillard M, Lemarié C, et al. Stenotrophomonas maltophilia susceptibility to ceftazidime-avibactam combination versus ceftazidime alone. Med Mal Infect. 2020;50(3):305–307. doi: 10.1016/j.medmal.2020.01.003.
  • Shirley M. Ceftazidime-Avibactam: a review in the treatment of serious gram-negative bacterial infections. Drugs. 2018;78(6):675–692. doi: 10.1007/s40265-018-0902-x.
  • Ehmann DE, Jahić H, Ross PL, et al. Kinetics of avibactam inhibition against class A, C, and D β-lactamases. J Biol Chem. 2013;288(39):27960–27971. Sepdoi: 10.1074/jbc.M113.485979.
  • Mojica MF, Papp-Wallace KM, Taracila MA, et al. Avibactam restores the susceptibility of clinical isolates of Stenotrophomonas maltophilia to aztreonam. Antimicrob Agents Chemother. 2017;61(10):e00777-17. Octdoi: 10.1128/AAC.00777-17.
  • Mojica MF, Ouellette CP, Leber A, et al. Successful treatment of bloodstream infection due to metallo-β-lactamase-producing Stenotrophomonas maltophilia in a renal transplant patient. Antimicrob Agents Chemother. 2016;60(9):5130–5134. Sepdoi: 10.1128/AAC.00264-16.
  • The European Committee on Antimicrobial Susceptibility Testing. Breakpoint tables for interpretation of MICs and zone diameters.Version 10.0, 2020. http://www.eucast.org
  • Romanelli F, De Robertis A, Carone G, et al. In vitro activity of ceftazidime/avibactam alone and in combination with fosfomycin and carbapenems against KPC-producing Klebsiella pneumoniae. New Microbiol. 2020;43(3):136–138.
  • Yang S, Hua M, Liu X, et al. Bacterial and fungal co-infections among COVID-19 patients in intensive care unit. Microbes Infect. 2021;23(4-5):104806. doi: 10.1016/j.micinf.2021.104806.
  • Gales AC, Jones RN, Forward KR, et al. Emerging importance of multidrug-resistant Acinetobacter species and Stenotrophomonas maltophilia as pathogens in seriously ill patients: geographic patterns, epidemiological features, and trends in the SENTRY antimicrobial surveillance program (1997-1999). Clin Infect Dis. 2001;32:S104–S113.
  • Lin Q, Zou H, Chen X, et al. Avibactam potentiated the activity of both ceftazidime and aztreonam against S. maltophilia clinical isolates in vitro. BMC Microbiol. 2021;21(1):60. doi: 10.1186/s12866-021-02108-2.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.